Liminal Biosciences Inc. (LMNL) Social Stream
Liminal BioSciences Inc (LMNL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering LMNL.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
LMNL's average price target has moved down $0.62 over the prior 26 weeks.
Over the past 48 weeks, LMNL's average upside potential has been 86.67%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
LMNL Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
LMNL's average broker recommendation rating improved by 0 over the prior 30 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LMNL as an investment opportunity.
- Liminal BioSciences Inc's average analyst price target is greater than 4.07% of all US stocks.
- LMNL has a higher number of analysts covering the stock than 46.07% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Liminal BioSciences Inc's variance in analysts' estimates is lower than -173.85% of them.
- In the context of stocks in the small market cap category, Liminal BioSciences Inc's upside potential (average analyst target price relative to current price) is greater than 274.39% of them.
In the Pharmaceutical Products industry, LIAN, LGVN, and LFVN are the three stocks most similar to Liminal BioSciences Inc regarding the price target and analyst recommendation information presented here.
Is LMNL a Buy, Hold or Sell? See the POWR Ratings now!